AKCA has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
AKCA has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
FFO (Funds from operations) only applies to REITs.
Michael J. Yang | director | C/O ACADIA PHARMACEUTICALS INC., 12830 EL CAMINO REAL, SUITE 400, SAN DIEGO CA 92130 |
Joseph Iii Klein | director | C/O GENAISSANCE PHARMACEUTICALS INC, FIVE SCIENCE PARK, NEW HAVEN CT 06511 |
Sandford D Smith | director | C/O ARIAD PHARMACEUTICALS INC, 26 LANDSDOWNE STREET, CAMBRIDGE MA 02139 |
B Lynne Parshall | director | 2855 GAZELLE COURT, CARLSBAD CA 92010 |
Joshua F. Patterson | officer: General Counsel | C/O AKCEA THERAPEUTICS, INC., 22 BOSTON WHARF ROAD, 9TH FLOOR, BOSTON MA 02210 |
Damien Mcdevitt | director, officer: Chief Executive Officer | C/O IONIS PHARMACEUTICALS, INC., 2855 GAZELLE COURT, CARLSBAD CA 92010 |
Alex G. Howarth | officer: Chief Operating Officer | C/O AKCEA THERAPEUTICS, INC., 22 BOSTON WHARF ROAD, 9TH FLOOR, BOSTON MA 02210 |
Kyle Jenne | officer: Chief Commercial Officer | C/O AKCEA THERAPEUTICS, INC. 22 BOSTON WHARF ROAD, 9TH FLOOR BOSTON MA 02210 |
William T. Andrews | officer: Chief Medical Officer | ONE MAIN STREET, SUITE 800, CAMBRIDGE MA 02142 |
Barbara Yanni | director | 1018 W. 8TH AVENUE, SUITE A, KING OF PRUSSIA PA 19406 |
Michael Dennis Price | officer: Chief Financial Officer | |
Elaine Hochberg | director | C/O AKCEA THERAPAEUTICS 55 CAMBRIDGE PKWY, STE 100 CAMBRIDGE MA 02142 |
Isis Pharmaceuticals Inc | 10 percent owner | 2855 GAZELLE COURT, CARLSBAD CA 92010 |
Michael F Maclean | officer: Chief Financial Officer | 14 CAMBRIDGE CENTER, CAMBRIDGE MA 02142 |
Paula Soteropoulos | director, officer: Chief Executive Officer | 49 WINONA STREET, PEABODY MA 01960 |
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.